US FDA to hold off action on weight-loss drug copies pending court ruling
The health regulator announced last month that there was no longer a shortage of Novo's Wegovy and diabetes drug Ozempic, ...
US judge denies injunction, restricting copies of Lilly weight-loss drug
A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and ...
Citi Sticks to Sell Rating on Hims & Hers (HIMS) Stock as FDA Ruling Clouds Outlook
Four-star-rated analyst Daniel Grosslight at Citi reiterated his Sell rating on Hims & Hers Health (HIMS) stock yesterday, ...
FDA update could extend Hims & Hers’ compounding timeline, says BofA
BofA analyst Allen Lutz notes that the Food and Drug Administration yesterday provided updated enforcement timelines for semaglutide and ...
Novo Nordisk Joins Legal Battle Over Weight Loss Drug Shortage
Novo Nordisk A/S can intervene in a lawsuit between the FDA and drug compounders over whether its blockbuster drugs Wegovy ...
UPDATE 2-US judge bars copies of Lilly weight-loss drug
The Outsourcing Facility Association, the lead plaintiff in this case, has said its estimates put the number of people taking compounded tirzepatide in the millions. Without a shortage, compounders ...
Federal judge stops compounded copies of Eli Lilly weight loss, diabetes drugs
A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...
JD Supra4d
Semaglutide Shortage Resolved
On February 21, 2025, the US Food and Drug Administration (FDA) revised its shortage categorization of semaglutide, a glucagon-like peptide 1 ...
Judge stops compounded copies of weight loss, diabetes drugs Zepbound, Mounjaro
A federal judge ended compounding pharmacies’ ability to make copies of the weight loss and diabetes drugs Zepbound and ...